AI Receptionist for private dermatology practices
Skin concerns are personal. The dermatology clinic that answers with expertise wins.
AI receptionist for private dermatology practices: Ava answers suspicious mole calls with appropriate urgency, captures the ABCDE change history, and books the dermatology consultation — before the caller talks themselves out of it.
A caller with a suspicious mole who reaches voicemail will frequently delay seeking help for weeks or months. In a melanoma case, that delay is clinically significant. A chronic skin condition patient returning quarterly is worth £800–£1,400 a year. Miss the first call and you miss the relationship.
The short answer
The problem
A patient has a suspicious mole they've been worrying about for months. They've finally called to get it checked. If they reach voicemail, anxiety kicks back in and they talk themselves out of booking. The call needs to be answered.
What Ava does
Ava answers every dermatology enquiry with expertise and reassurance, captures the presenting skin concern, duration, and any changes, and books the dermatology consultation — transforming anxious delay into a confirmed appointment.
A private dermatology consultation: £200–£350. A mole removal or biopsy: £400–£1,200. A chronic skin condition patient (eczema, psoriasis, rosacea) returns quarterly = £800–£1,400/year.
How does Ava apply urgency to a suspicious mole call without making a diagnosis?
Ava asks about recent changes using the ABCDE criteria in plain language — has it changed shape, grown in size, changed colour, developed irregular edges, or done anything new in the last few months? Any affirmative answer to a recent change prompts an urgent slot within one to two weeks. She books; your dermatologist diagnoses.
Mole change calls are where clinical urgency and booking function must intersect precisely. Under-responding — treating a mole that has changed shape and colour as a routine concern — delays a potentially urgent dermatological assessment. Over-responding — creating alarm before a dermatologist has assessed the lesion — causes unnecessary distress. Ava avoids both by asking the right questions and booking the urgency tier the answers indicate.
The ABCDE framework for melanoma detection is the standard taught to both clinicians and patients. Ava applies it in plain English without using the terminology in a way that alarms the caller. 'Has it changed shape?' is the asymmetry question. 'Has it grown in size or spread out?' is the diameter question. 'Has it changed colour or developed darker or lighter patches?' covers the colour criterion. The answers tell Ava which slot to offer.
For callers who are clearly anxious but unable to describe the mole clearly, Ava books the appointment on the basis of their concern rather than waiting for a description they cannot provide. An anxious caller who cannot articulate the change they have noticed deserves a same-week appointment, not a reassurance that it is 'probably fine'.
Why are immunosuppressed patients the highest-priority dermatology callers?
Patients on long-term immunosuppression — organ transplant recipients on tacrolimus or cyclosporine, patients on biologics for IBD or rheumatoid arthritis, HIV-positive individuals with low CD4 counts — have significantly elevated rates of squamous cell carcinoma and other skin malignancies. A mole check or skin concern in this population warrants prompt assessment. Ava captures immunosuppression and flags it.
Organ transplant recipients on calcineurin inhibitors develop squamous cell carcinoma at rates 65 to 250 times higher than the general population. The lesions are often multiple, can progress rapidly, and occur in unusual locations. A transplant recipient calling about any suspicious skin lesion should be seen within one to two weeks regardless of how unremarkable the description sounds over the phone.
Patients on biologic therapies — adalimumab, infliximab, ustekinumab — for conditions like Crohn's disease, ulcerative colitis, and psoriatic arthritis also carry elevated skin cancer risk, particularly for non-melanoma skin cancers. Ava captures the biologic medication name, notes the immunosuppressed status, and flags it to your dermatologist so they know before the appointment that this is a higher-risk clinical context.
For patients who are on long-term oral steroids, methotrexate, or hydroxychloroquine for autoimmune conditions, Ava captures the medication and routes to your dermatologist with the appropriate flag. Immunosuppression is not always volunteered by callers who do not connect their arthritis medication to their skin cancer risk — Ava asking about current medications surfaces this clinical data reliably.
How does Ava handle chronic skin condition calls for eczema, psoriasis and rosacea?
Ava captures the condition, duration, current and previous treatments tried, and any specific concern prompting the call — a flare, a treatment that has stopped working, or a new skin change. Chronic skin condition patients are a high-value recurring revenue stream; the call that books the first private consultation often converts to a quarterly review relationship.
Eczema, psoriasis and rosacea patients often present having exhausted GP options — repeated short courses of topical steroids, a GP who has limited familiarity with newer biologics, or a diagnosis that has taken years and several incorrect treatments. They are presenting to a private dermatologist because they want someone who specialises. Ava's knowledge of these conditions and their treatment landscape signals expertise before the appointment.
For psoriasis patients asking about biologic therapy — adalimumab, secukinumab, risankizumab — Ava explains that biologics are assessed and prescribed at the consultation, captures the severity and treatment history, and books a consultation with enough time for your dermatologist to review appropriately. A patient requesting biologic therapy needs a different appointment format than a routine psoriasis review.
Chronic skin condition patients who are retained quarterly generate £800–£1,400 in annual consultation revenue per patient, with additional prescription management and cosmetic dermatology add-ons. The first call that books the initial consultation is the entry point to a multi-year clinical relationship.
£800–£1,400
Annual consultation revenue from a retained chronic skin condition patient
UK private dermatology industry estimate
2 weeks
Target timeframe for seeing a mole with recent change — mirroring the NHS 2WW standard privately
UK dermatology clinical standard
65–250×
Elevated SCC risk in solid organ transplant recipients on calcineurin inhibitors
UK dermatology clinical literature
The difference
Voicemail takes a message. Ava books the appointment.
What callers ring about
Every dermatology call, handled.
- Suspicious mole and skin cancer check bookings
- Acne, eczema and psoriasis consultations
- Cosmetic dermatology enquiries
- Chronic skin condition programme reviews
Hear it in action
This is what your callers hear.
- Good morning, SkinFirst Dermatology — how can I help?
- I have a mole that's changed shape recently and I'm a bit worried about it.
- You're right to get it checked — any change is worth a proper look. How long ago did you notice the change, roughly?
- About three weeks ago.
- I'd like to book you an urgent mole check this week. We have Thursday at 11am — does that work?
Before you choose
What to look for in an AI receptionist for dermatology.
ABCDE-based urgency for mole calls
The AI must ask about recent changes using the melanoma criteria — shape, size, colour, border irregularity, evolution — and apply urgency accordingly. A service that routes all mole calls to the next available routine slot is clinically inadequate.
Immunosuppression capture as a priority flag
Transplant recipients and patients on biologics have dramatically elevated skin cancer risk. The AI must ask about immunosuppressant medications and flag positive responses as priority for your dermatologist.
Treatment history for chronic skin conditions
A psoriasis patient asking about biologics has a different clinical context from one presenting for the first time. Capturing treatment history allows your dermatologist to allocate the right appointment length and prepare the appropriate discussion.
Anxiety-appropriate tone for mole callers
Mole callers are often frightened. The AI must acknowledge their concern without creating additional alarm, explain that the dermatologist will assess properly, and book promptly. Phrases like 'it's probably nothing' are as unhelpful as unnecessary alarm.
Common questions
Everything you’re wondering.
Can Ava handle calls about suspicious moles and skin cancer concerns?
Yes. Ava treats these calls with appropriate urgency, captures the mole's size, location, and any recent changes (the ABCDEs), and prioritises urgent slots where the concern warrants it.
What skin conditions does Ava handle enquiries for?
Acne, eczema, psoriasis, rosacea, mole checks, skin tags, warts, hair loss (alopecia), nail conditions, and cosmetic dermatology — covering the full scope of private dermatology practice.
Can Ava handle calls about cosmetic dermatology treatments?
Yes. Ava handles enquiries about prescription retinoids, chemical peels, PRP for hair loss, and other dermatologist-led cosmetic treatments — booking consultations where appropriate.
Does Ava capture dermatology pre-consultation information?
Yes. Ava captures presenting skin condition, duration, any previous treatments tried, and relevant health history (immunosuppression, medications) — giving your dermatologist a meaningful pre-consult brief.
How does Ava apply urgency to a suspicious mole call?
Ava asks about recent changes using the ABCDE framework in plain language — asymmetry, border irregularity, colour change, diameter growth, evolution — and prioritises an urgent appointment within one to two weeks for any mole that has recently changed. She does not diagnose, but she does not delay.
Can Ava handle a caller on immunosuppressant medication asking for a skin check?
Yes. Immunosuppressed patients — transplant recipients on tacrolimus, patients on biologics for inflammatory conditions — have significantly elevated skin cancer risk. Ava captures the immunosuppression and flags it as a priority, since your dermatologist will want to see these patients promptly for a full skin check.
Can Ava book NHS pathway-equivalent urgent two-week-wait referrals in a private setting?
Ava identifies concerning mole descriptions and offers the earliest available appointment — typically within one to two weeks — to mirror the NHS 2WW urgency standard in a private context. She captures enough information for your dermatologist to confirm the priority at the appointment.
Does Ava integrate with dermatology practice software?
Yes. Consultations write into Semble, Heydoc or Cliniko with presenting condition, duration, recent changes and relevant health history noted, so your dermatologist opens the appointment with a clinically useful brief.
Pricing
Ava pays for herself on call one.
A private dermatology consultation: £200–£350. A mole removal or biopsy: £400–£1,200. A chronic skin condition patient (eczema, psoriasis, rosacea) returns quarterly = £800–£1,400/year. Plans from £397/mo. One recovered job a month covers it — everything else is pure upside.
More Private GP & Specialist Clinics sectors
Start your free trial. Ava answers your dermatology calls within 48 hours.
No sales calls. No contracts. 5 days free, cancel any time — with the 10-booking guarantee on top.
Start free trial →